HEALTH
The findings were released at the American Society of Clinical Oncology (ASCO) meeting in Chicago, the world's largest annual cancer conference.
Two major studies released today show that many people with breast and lung cancers may forgo chemotherapy and still live longer, signaling a waning need for what was long seen as the standard of cancer care.
The findings were released at the American Society of Clinical Oncology (ASCO) meeting in Chicago, the world's largest annual cancer conference.
The first study, described as the largest breast cancer treatment trial to date, found that the majority of women with a common form of breast cancer may be able to skip chemotherapy and its toxic, and often debilitating, side effects after surgery depending on their score on a genetic test.
As many as 65,000 women in the United States alone could be affected by the findings.
Until now, women have faced considerable uncertainty about whether to add chemo to hormone therapy after a diagnosis with hormone-receptor positive, HER-2 negative breast cancer when found at an early stage, before it has spread to the lymph nodes.
"With results of this groundbreaking study, we now can safely avoid chemotherapy in about 70 percent of patients who are diagnosed with the most common form of breast cancer," said co-author Kathy Albain, an oncologist at Loyola Medicine in a Chicago suburb.
A 21-gene test called Oncotype DX, available since 2004, has helped guide some decisions on proper care after surgery.
A high recurrence score, above 25, means chemo is advised to ward off a recurrence, while a low score, below 10, means it is not.
The current study focused on those whose scores were in the middle range, from 11 to 25.
More than 10,000 women, aged 18 to 75, were randomly assigned to receive chemotherapy followed by hormone therapy, or hormone therapy alone. Researchers studied their outcomes, including whether or not cancer recurred, and their overall survival.
"For the entire study population with gene test scores between 11 and 25 -- and especially among women aged 50 to 75 -- there was no significant difference between the chemotherapy and no chemotherapy groups," said the findings, published in the New England Journal of Medicine.
The results show that all women over 50 with a recurrence score of 0 to 25 can be spared chemotherapy and its toxic side effects.
For women under 50 with a score of 0 to 15, chemo can be skipped. However, among younger women with scores 16 to 25, outcomes were slightly better in the chemotherapy group, so in those cases doctors may urge patients to consider a chemo regimen.
The results "should have a huge impact on doctors and patients," Albain said.
"We are de-escalating toxic therapy."
According to first author Joseph Sparano of Montefiore Medical Center in New York, "any woman with early-stage breast cancer 75 or younger should have the test and discuss the results" with her doctor.
Breast cancer is the leading cause of cancer death in women worldwide, causing some 1.7 million new cases annually and over half a million deaths. The study's primary funding came from the US National Institutes of Health (NIH).
The second study tested a form of immunotherapy against chemo, in the most common lung cancer worldwide, known as non-small-cell lung cancer. It found that Merck pharmaceutical's drug Keytruda (pembrolizumab) -- which famously helped former US president Jimmy Carter stave off advanced melanoma that had spread to his brain -- helped lung cancer patients live four to eight months longer than chemo.
More than 1,200 people enrolled in the study, the largest clinical trial to date of pembrolizumab as a stand-alone therapy for lung cancer. The drug was approved in 2014 for melanoma and in 2015 for lung cancer.
"These are responses that are unlike anything we have seen in the past for non-small-cell lung cancer," said lead author Gilberto Lopes, a medical oncologist at the University of Miami Health Center.
Still, he acknowledged that most patients with this form of advanced cancer will die within months, and "we need to do a lot more work." Lung cancer is the leading cause of cancer death worldwide, taking 1.7 million lives per year.
John Heymach, a professor at the University of Texas MD Anderson Cancer Center who was not involved in the Merck-funded study, described it as a "true milestone" and "a real important advance for patients." "We are now leaving an era where the only choice for non-small-cell lung cancer patients was to start with chemotherapy," he told reporters at the ASCO conference.
"Now, the vast majority of patients can potentially receive benefits from immunotherapy instead," he added.
"Immunotherapy is here to stay for the vast majority of non-small-cell lung cancer patients as a first-line treatment."
Types, Most Popular and Where to Buy Peptides for Bodybuilding
Luxury in the City of Light: SABO Boutique Hotel Brings Elegance to Varanasi’s Sacred Ghats
Virat Kohli, Babar Azam could play for same team as Afro-Asia Cup set for revival
Shaping the Future of Web Apps: Full Stack Developer’s Expertise in API Design and Cloud Deployment
The Role of Artificial Intelligence in Enhancing Software Performance and Security
Mastering Linux for Superior Sound
AI in Data Warehousing: Future Trends and Innovations
Mukesh Ambani's Reliance Jio IPO worth Rs 840960 crore in 2025: All you need to know
After India's 0-3 loss against New Zealand, Shah Rukh Khan calls Gautam Gambhir...
BIG revelation on Imane Khelif, Olympic gold medallist boxer's medical repot leaked, it confirms…
Meet man who built Rs 152000 crore company, donated Rs 100 crore, now set to lead US firm as...
Visa Uncertainty: Impact of US polls on global talent
Virat Kohli turns 36: IPL franchises send heartwarming birthday wishes to legendary India cricketer
Meet Sanjay Verma, the new DGP of Maharashtra who replaced Rashmi Shukla
Anushka Sharma shares FIRST photo of Akaay, Vamika to celebrate Virat Kohli’s birthday
CAT 2024 admit card to be out today at iimcat.ac.in; know release time, steps to download
Vikas Divyakirti UPSC Tips: Check strategy to crack IAS exam, aspirants should study for...
Video of Pakistani man putting hand into chained tiger's mouth goes viral, social media reacts
Shalini Passi reveals her husband's connection to Shah Rukh Khan's wife Gauri Khan, they were..
SC upholds validity of UP madrassa law, says it does not violate principle of secularism
US Presidential Elections 2024: What time do the polls close; when will the results be known?
Elon Musk shares controversial post on X amid US election results, video goes viral
Mukesh Ambani's company earned Rs 15393 crore last week, his net worth now stands at...
Chhath Puja 2024: Know about Kharna, Sandhya Arghya, Usha Arghya, date, timings and puja vidhi
Virat Kohli Birthday: Legendary batter turns 36, here's a look at his incredible milestones
When Ratan Tata met his first true love after 50 years, went for dinner together, know who she was
Samantha Ruth Prabhu hits back at trolls who body-shamed her: 'If you guys...'
Two fall prey to Narayana Murthy and Mukesh Ambani's deepfake videos, lose Rs 80 lakh: Report
North Korea fires multiple ballistic missiles toward sea ahead of US election
Deepika Padukone romances Hrithik Roshan in Bikini, looks sizzling hot in UNSEEN viral video
Chhath Puja 2024: Top 50 wishes, What'sApp messages, quotes to share with your loved ones
Meet Caroline Emmons, Ratan Tata's 'first love' with whom he couldn't marry due to...
Who is Rohan Jaitley, frontrunner to replace Jay Shah as BCCI secretary?
World’s most expensive human tooth is valued over Rs 3000000, it belonged to…
Viral video: Little girl’s adorable dance to Lisa Haydon’s 'Manali Trance' impresses internet, watch
SC to deliver its verdict on pleas against Allahabad HC order scrapping UP madrasa law today
DNA TV Show: Why Election Commission changed Assembly by-elections' dates
Days after imposing fine on Anil Ambani, Sebi now issues Rs 130 crore demand notices to...
Thailand announces indefinite visa-free entry for Indian travellers
Meet daughter of billionaire, who studied in UK, now works in Rs 32770 crore Indian company as...
MUDA case: Lokayukta police summon Karnataka CM Siddaramaiah for questioning on...
This city is 4000 years old, belongs to bronze age where 500 people lived, it is located in...
Kamala Harris has been the President of US before? Here's when and how
What is elimination inflammation diet that helped Vidya Balan lose weight?
Shah Rukh Khan feels breathless after quitting smoking: Know withdrawal symptoms, how to manage them
Zomato CEO Deepinder Goyal takes action on vendor for mislabelling mushrooms at Hyperpure warehouse
Mukesh Ambani's Reliance shares fell by 3%, loses Rs 50205 crore in one day due to...
IAF's MiG-29 crashes near Agra in Uttar Pradesh, pilot ejects safely, court of inquiry ordered
Driving Growth and Monetization at Zendesk: A Conversation with Darshit Thakkar